Form 4: Corcept CDO Gifts 200 Shares to Charity

Corcept Therapeutics' Chief Development Officer, William Guyer, reported gifting 200 shares of common stock to a charitable account.

Summary

• William Guyer, Chief Development Officer of Corcept Therapeutics Inc. (CORT), reported a transaction involving company common stock.
• On September 19, 2025, Guyer disposed of 200 shares of CORT common stock.
• This transaction was a gift (transaction code 'G') to a Fidelity Charitable Giving Account, with a reported price of $0 per share.
• Following this donation, Guyer's direct beneficial ownership stands at 5,287 shares of CORT common stock.

Sentiment

Score: 5

Explanation: The filing reports a routine insider gift transaction, which is generally neutral. It does not indicate significant changes in company performance or insider sentiment regarding the stock's future value.

Positives

• The transaction represents a charitable donation by a company executive, which can be viewed positively from a corporate social responsibility perspective.

Negatives

• The transaction involves a reduction in direct insider ownership, albeit a small amount and for charitable purposes.

Future Outlook

This filing is an insider transaction report and does not contain forward-looking statements or guidance regarding the company's future performance or outlook.

Industry Context

This filing reports a routine insider stock transaction and does not provide information related to broader industry trends or competitive landscape.

Stakeholder Impact

• Shareholders: A minor reduction in direct insider ownership, but for charitable purposes, which is generally not viewed negatively.
• Employees: No direct impact mentioned.

Key Dates

Keywords

CORCEPT THERAPEUTICS, CORT, William Guyer, Chief Development Officer, Insider Transaction, Stock Donation, Form 4, Charitable Giving